Keppra Loading Dose
For adults with status epilepticus, use levetiracetam 40-60 mg/kg IV (maximum 4500 mg) as a loading dose, infused over 15 minutes. For routine seizure management without status epilepticus, no loading dose is typically required—start with standard maintenance dosing.
Adults (≥16 years)
Status Epilepticus Context
The most robust evidence comes from pediatric CAR-T cell therapy guidelines, which recommend levetiracetam 40 mg/kg IV bolus (maximum 2500 mg) for both convulsive and non-convulsive status epilepticus 1. However, the FDA label does not specify a loading dose for adults 2.
For benzodiazepine-refractory status epilepticus:
- Loading doses ranging from 20-60 mg/kg have been studied 3
- Higher doses (≥40 mg/kg) showed no additional benefit in seizure termination but were associated with increased intubation rates (45.8% vs 26.8-28.2%) 3
- Practical recommendation: Use 40 mg/kg IV (maximum 4500 mg) over 15 minutes as this balances efficacy with safety
Routine Seizure Management (Non-Emergency)
The FDA label recommends no loading dose for partial-onset seizures 2:
- Start with 500 mg twice daily
- Increase by 1000 mg/day every 2 weeks to target dose of 3000 mg/day
- For myoclonic or primary generalized tonic-clonic seizures: start 1000 mg/day (500 mg BID), increase to 3000 mg/day
Pediatric Patients
Status Epilepticus (Convulsive or Non-Convulsive)
Use 40 mg/kg IV bolus (maximum 2500 mg) in addition to maintenance dosing 1:
- Infuse over 15 minutes
- Follow with age-appropriate maintenance doses
Routine Seizure Management by Age 2:
1 month to <6 months:
- Start 14 mg/kg/day divided BID (7 mg/kg twice daily)
- Target: 42 mg/kg/day (21 mg/kg BID)
6 months to <4 years:
- Start 20 mg/kg/day divided BID (10 mg/kg twice daily)
- Target: 50 mg/kg/day (25 mg/kg BID)
4 years to <16 years:
- Start 20 mg/kg/day divided BID (10 mg/kg twice daily)
- Target: 60 mg/kg/day (30 mg/kg BID)
- Maximum: 3000 mg/day
Pediatric loading dose evidence: A prospective study demonstrated that 50 mg/kg IV (maximum 2500 mg) over 15 minutes was safe and well-tolerated in children 6 months to <15 years, achieving therapeutic levels (mean 83.3 mcg/mL) 4.
Renal Impairment
Adults with Renal Dysfunction 2:
Dosing adjustments based on creatinine clearance:
| CrCl (mL/min/1.73m²) | Dosage | Frequency |
|---|---|---|
| >80 (Normal) | 500-1500 mg | Every 12 hours |
| 50-80 (Mild) | 500-1000 mg | Every 12 hours |
| 30-50 (Moderate) | 250-750 mg | Every 12 hours |
| <30 (Severe) | 250-500 mg | Every 12 hours |
| ESRD on dialysis | 500-1000 mg* | Every 24 hours |
*Give 250-500 mg supplemental dose after dialysis
Continuous Renal Replacement Therapy (CRRT)
Critical consideration: Levetiracetam clearance during CRRT is similar to healthy adults with normal renal function 5. Standard "renal dosing" may result in subtherapeutic levels.
For patients on CRRT:
- Use 60 mg/kg loading dose (maximum 4500 mg) 5
- Maintenance: 750-1000 mg twice daily (not reduced doses) 5
- CRRT accounts for 52-73% of total drug clearance 5
- Monitor therapeutic drug levels (target trough: 12-46 mcg/mL)
Augmented Renal Clearance (ARC)
In critically ill patients with CrCl >130 mL/min:
- Standard doses (500-1500 mg BID) are insufficient 6, 7
- Recommend at least 1500 mg twice daily for maintenance 7
- Consider doses up to 3000 mg BID in extreme ARC 6
- Levetiracetam clearance can reach 6.5 L/h (vs 3.8 L/h in healthy adults) 7
Key Clinical Pitfalls
Common dosing errors:
- Over-reducing doses in renal failure during CRRT—this leads to treatment failure 5
- Using inadequate loading doses in status epilepticus—delays therapeutic levels 3
- Missing ARC in critically ill patients—results in subtherapeutic concentrations 6, 7
Administration specifics:
- Dilute in 100 mL compatible diluent (NS, LR, D5W) 2
- Maximum concentration: 15 mg/mL 2
- Infusion time: 15 minutes 2
- Compatible with lorazepam, diazepam, valproate 2
Therapeutic drug monitoring is essential when: